State NC
Clinical Trials in North Carolina
Recruiting clinical trials with at least one study location in North Carolina. Data updated daily from ClinicalTrials.gov.
Top Conditions in North Carolina
NCT07145229 Phase 2
Recruiting
Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare
Condition
Acute Gouty Arthritis
Enrollment
380 pts
Location
United States, Australia, China
Sponsor
Atom Therapeutics Co., Ltd
NCT04097145 N/A
Recruiting
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
Condition
Tricuspid Regurgitation
Enrollment
870 pts
Location
United States, Canada
Sponsor
Edwards Lifesciences
NCT07225686 Phase 3
Recruiting
Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sl...
Condition
Obesity
Enrollment
250 pts
Location
United States, Australia, Canada
Sponsor
Amgen
NCT05504837 Phase 1
Recruiting
A Study Assessing KB407 for the Treatment of Cystic Fibrosis
Condition
Cystic Fibrosis
Enrollment
12 pts
Location
United States
Sponsor
Krystal Biotech, Inc.
NCT07221500 Phase 2
Recruiting
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyr...
Condition
Chronic Lymphocytic Leukemia (CLL)
Enrollment
100 pts
Location
United States, France, Italy
Sponsor
Nurix Therapeutics, Inc.
NCT04951622 Phase 3
Recruiting
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
Condition
Myasthenia Gravis
Enrollment
199 pts
Location
United States, Australia, Belgium
Sponsor
Janssen Research & Development
NCT06960837 N/A
Recruiting
Ultrasound Simulation Case-based Workshop Implementation and Impact Assessment
Condition
Point-of-care Ultrasound
Enrollment
100 pts
Location
United States
Sponsor
Duke University
NCT06841575 N/A
Recruiting
Advancing Pediatric Retinal Imaging With Auto-aligned OCT
Condition
Eye Diseases
Enrollment
50 pts
Location
United States
Sponsor
Duke University
NCT07037901 Phase 2
Recruiting
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants Wit...
Condition
Atopic Dermatitis
Enrollment
220 pts
Location
United States, Canada
Sponsor
Inmagene LLC
NCT05797831 Phase 2, Phase 3
Recruiting
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endo...
Condition
Endometrial Cancer
Enrollment
268 pts
Location
United States, Austria, Canada
Sponsor
Kartos Therapeutics, Inc.
NCT06303739 Phase 3
Recruiting
Psilocybin-Assisted Therapy in Treatment-Resistant Depression
Condition
Refractory Depression
Enrollment
23 pts
Location
United States
Sponsor
University of North Carolina,
NCT06618274 N/A
Recruiting
Effectiveness of Central Oncology Navigation and the Use of an ORN
Condition
Cancer
Enrollment
686 pts
Location
United States
Sponsor
UNC Lineberger Comprehensive C
NCT06972459 Phase 3
Recruiting
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight a...
Condition
Obesity
Enrollment
600 pts
Location
United States, Argentina, China
Sponsor
Eli Lilly and Company
NCT05546580 Phase 1
Recruiting
Study of Iadademstat and Gilteritinib in Patients With R/R AML With FMS-like Tyr...
Condition
Acute Myeloid Leukemia, in Relapse
Enrollment
50 pts
Location
United States
Sponsor
Oryzon Genomics S.A.
NCT07234201 N/A
Recruiting
Virtual Reality Use for ICU Mobility
Condition
Intensive Care Unit ICU
Enrollment
60 pts
Location
United States
Sponsor
Duke University
NCT05241990 N/A
Recruiting
Practice Facilitation as a Strategy to Improve Alcohol Treatment Adoption and Im...
Condition
Hiv
Enrollment
300 pts
Location
United States
Sponsor
Johns Hopkins University
NCT05327686 Phase 2
Recruiting
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for t...
Condition
Metastatic Renal Cell Carcinoma
Enrollment
240 pts
Location
United States, Australia, Canada
Sponsor
NRG Oncology
NCT05803941 Phase 4
Recruiting
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With ...
Condition
Prostate Cancer
Enrollment
700 pts
Location
United States, Austria, Belgium
Sponsor
Novartis Pharmaceuticals
NCT06738394 N/A
Recruiting
Enhancing Physical Function in Older Adults With Chronic Kidney Disease
Condition
Chronic Kidney Diseases
Enrollment
30 pts
Location
United States
Sponsor
Wake Forest University Health
NCT07226895 Phase 1, Phase 2
Recruiting
A Study Exploring Changes in a Variety of Biomarkers Following Dosing With MT198...
Condition
Clinical High Risk for Psychosis (CHR)
Enrollment
150 pts
Location
United States
Sponsor
Monument Therapeutics Limited
NCT06659029 N/A
Recruiting
Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab U...
Condition
Systemic Lupus Erythematosus
Enrollment
442 pts
Location
United States
Sponsor
AstraZeneca
NCT06568237 Phase 2
Recruiting
A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Mul...
Condition
Multiple System Atrophy
Enrollment
350 pts
Location
United States, France, Germany
Sponsor
Teva Branded Pharmaceutical Pr
NCT06679140 Phase 3
Recruiting
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolesc...
Condition
COVID-19 SARS-CoV-2 Infection
Enrollment
2,330 pts
Location
United States, Argentina, Belgium
Sponsor
Pfizer
NCT06384261 Phase 2
Recruiting
A Study Comparing Venetoclax and Azacitidine Plus Cusatuzumab to Venetoclax and ...
Condition
Leukemia, Myeloid, Acute
Enrollment
120 pts
Location
United States, Canada, Germany
Sponsor
OncoVerity, Inc.
NCT04462770 Phase 3
Recruiting
A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrom...
Condition
Dravet Syndrome
Enrollment
150 pts
Location
United States, Canada, Georgia
Sponsor
Epygenix